My innovation story began not in a lab, but in an operating room.
At 28, I was diagnosed with an 18 cm uterine fibroid pressing against my uterus, colon, and bladder. The situation was critical, I nearly lost all three organs, and almost my life.
After surgery, I learned that what happened to me wasn’t rare. Uterine fibroids affect up to 70% of women by age 50, yet most solutions are reactive — focused on removal, not prevention. Women are told to “just manage it,” and that silence almost cost me everything.
As a pharmacologist and the COO of Go Vertical ICM and Michael & Hope, I decided to use my scientific background and innovation leadership to change that narrative. I founded The Hope Project, a femtech initiative focused on preventing fibroids and fibroadenomas through a clinically designed botanical supplement and a digital platform that tracks hormonal health and symptoms in real time.
This project bridges research, technology, and lived experience to give women early insight, control, and confidence in their health. What began as a personal journey of survival has become a movement, turning pain into prevention and creating space for women to be heard, believed, and healed.